CRH (CRH)
(Delayed Data from NYSE)
$78.55 USD
+1.35 (1.75%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $78.58 +0.03 (0.04%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth A Momentum C VGM
Income Statements
Fiscal Year end for CRH PLC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 34,949 | 32,723 | 30,981 | 27,587 | 28,144 |
Cost Of Goods | 22,986 | 21,844 | 20,493 | 18,425 | 18,868 |
Gross Profit | 11,963 | 10,879 | 10,488 | 9,162 | 9,277 |
Selling & Adminstrative & Depr. & Amort Expenses | 7,486 | 7,034 | 6,784 | 6,890 | 6,485 |
Income After Depreciation & Amortization | 4,477 | 3,845 | 3,704 | 2,272 | 2,792 |
Non-Operating Income | -87 | 25 | -51 | -219 | -36 |
Interest Expense | 376 | 401 | 311 | 389 | 388 |
Pretax Income | 4,014 | 3,469 | 3,342 | 1,664 | 2,369 |
Income Taxes | 925 | 785 | 721 | 499 | 534 |
Minority Interest | -106 | 27 | 56 | 43 | 21 |
Investment Gains/Losses | -17 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3,072 | 2,684 | 2,621 | 1,165 | 1,835 |
Extras & Discontinued Operations | 0 | 1,190 | 0 | 0 | 347 |
Net Income (GAAP) | 3,178 | 3,847 | 2,565 | 1,122 | 2,160 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 6,110 | 5,602 | 5,469 | 3,966 | 4,581 |
Depreciation & Amortization (Cash Flow) | 1,633 | 1,757 | 1,765 | 1,694 | 1,789 |
Income After Depreciation & Amortization | 4,477 | 3,845 | 3,704 | 2,272 | 2,792 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 729.20 | 764.10 | 786.80 | 791.10 | 807.79 |
Diluted EPS Before Non-Recurring Items | 4.62 | 3.48 | 3.26 | 1.42 | 2.56 |
Diluted Net EPS (GAAP) | 4.33 | 5.03 | 3.26 | 1.42 | 2.68 |
Fiscal Year end for CRH PLC falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 8,685.00 | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | 701.00 | NA | NA | NA |
Extras & Discontinued Operations | NA | 0.00 | NA | NA | NA |
Net Income (GAAP) | NA | 701.00 | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 705.30 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | 1.29 | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | 0.99 | NA | NA | NA |